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Objective: To determine the predictive value of unicompartimental joint space narrowing (JSN) for MRI-
based cartilage thickness loss in the narrowed and the non-narrowed femorotibial compartment.
Methods: 922 knees from 922 Osteoarthritis Initiative (OAI) participants (62.2  9.0 years, 61% females)
with radiographic OA (158 without JSN [noJSN], 175 with lateral JSN [latJSN], 589 with medial JSN
[medJSN]) were analyzed using 3 T MRI. One-year cartilage thickness change was determined in the
lateral (LFTC) and medial femorotibial compartment (MFTC), and in femorotibial subregions. The prob-
ability of subsequent cartilage loss was calculated using predeﬁned thresholds. The predictive value of
JSN for the probability and magnitude of cartilage loss was compared between latJSN, medJSN and noJSN
knees using Fisher’s exact and ManneWhitney-U tests.
Results: The probability of cartilage loss was greater in the narrowed compartment of latJSN/medJSN
knees (34.9%/32.4%) than in noJSN knees (13.3%/12.7%, P  6.4  106) and so was the magnitude of
cartilage thickness change (P  8.2  106). No signiﬁcant differences were observed between the
narrowed compartments of latJSN vs medJSN knees (probability: P ¼ 0.58, magnitude: P ¼ 0.19) or
between the non-narrowed compartment of latJSN/medJSN vs noJSN knees (probability: P  0.35,
magnitude: P ¼ 0.23). These results were conﬁrmed by the location-independent ordered value (OV)
analyses of femorotibial subregions.
Conclusion: The predictive value of latJSN for lateral compartment cartilage loss was comparable to that
of medJSN for medial compartment cartilage loss, whereas cartilage loss in the non-narrowed
compartment was similar to that in noJSN knees. These ﬁndings provide important clues to predicting
progression of knee OA, and in tailoring inclusion criteria for clinical trials.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) is a slowly progressing disease with a
high prevalence in elderly people1. Predicting who will (and who
will not) progress symptomatically and/or on a structural levelW. Wirth, Institute of Anat-
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s Research Society International. Ptherefore is important from a clinical management perspective.
Cartilage thickness change is a hallmark of OA and change in the
femorotibial joint was reported to be indistinguishable from
healthy reference subjects in the early stages of radiographic OA
(ROA; i.e., Kellgren & Lawrence grade [KLG] 2)2,3, potentially
because cartilage thinning and thickening occur simultaneously at
this stage4,5. Greater and more uniform cartilage loss was observed
in knees with advanced ROA (KLG 3 or 4)3,6, in which joint space
narrowing (JSN) was evident on baseline radiographs. Previous
studies have reported that medial JSN was a strong predictor of
subsequent structural progression in the medial femorotibial
compartment (MFTC) 7; however whether lateral JSN is a predictor
of lateral (or medial) femorotibial cartilage loss is currentlyublished by Elsevier Ltd. All rights reserved.
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or medial JSN with cartilage loss in the non-narrowed femorotibial
compartment has not been previously reported.
The objective of this study therefore was to determine the
predictive value of unicompartimental lateral or medial JSN for
subsequent cartilage thickness loss in both the narrowed and the
non-narrowed femorotibial compartmentwhen compared to knees
without JSN.
Methods
The study was performed using data from the Osteoarthritis
Initiative (OAI, clinicaltrials.gov identiﬁer: NCT00080171, http://oai.
ucsf.edu/), an on-going multi-center study targeted at identifying
and validating biomarkers for knee OA. At baseline, the OAI cohort
included 4,796 participants aged 45e79 years. General exclusion
criteria were presence of rheumatoid or other inﬂammatory
arthritis, bilateral end-stage knee OA, inability towalk without aids,
and MRI contraindications8. At each of the annual visits, the OAI
collected clinical data and acquired both 3 T MRI of the knees9 and
bilateral ﬁxed-ﬂexion radiographs (8). Semi-quantitative readings
of medial and lateral JSN and osteophyte grades were based on the
OARSI atlas10 and were performed centrally by experienced readers
from Boston University, using the bilateral ﬁxed-ﬂexion radio-
graphs. Baseline and follow-up radiographs of each knee were
independently assessed by two readers with the baseline radio-
graph identiﬁed to the readers and the follow-up radiographs
randomly ordered. Discrepancies between readings were adjudi-
cated with a third reader present.
Subject selection
Longitudinal cartilage thickness measurements were available
for two subsamples of the OAI8: In 906 knees, baseline and 1 year
follow-up measurements were available from coronal FLASH ac-
quisitions3,9. In 565 knees, baseline, 1 year and 2-year follow-up
measurements were available from sagittal DESS acquisitions9,11.
The selection process of both subcohorts has been published pre-
viously3,8,11 and both MR protocols have been validated and
compared directly with respect to quantitative assessments of
cartilage loss12,13.
Only knees with deﬁnite ROA according to the central readings8
were included in the current analysis, with deﬁnite ROA being
deﬁned as deﬁnite osteophytes with or without (medial or lateral)
JSN. For this analysis, cartilage thickness measurements at baseline
and 1 year follow-up were included. We studied only one knee per
participant to avoid the need to take correlation between in-
dividuals’ knees into account14,15. From the 544 (of 906) radio-
graphically eligible knees of the FLASH subsample and 541 (of 565)Fig. 1. MC and 95% CIs of the change in cartilage thickness in knees without JSN (noJSN), wit
MFTC.eligible knees of the DESS subsample, 27 knees (12 FLASH, 15 DESS)
were excluded because of bicompartimental (medial and lateral)
JSN, and nine knees (all DESS) in subjects with data from both
knees. From the remaining 532/517 FLASH/DESS knees, 127 were
overlapping between both subsamples and were excluded from the
larger FLASH subsample. The remaining 405 FLASH and 517 DESS
knee image pairs (baseline and 1 year follow-up) from 922 par-
ticipants were pooled for the analyses16.MRI-based measurement of cartilage thickness
Cartilage thickness measurements were based on manual seg-
mentations as described previously3,16. After quality control of each
MR data set by one expert (M.H.), segmentation of the weight-
bearing femorotibial cartilages in paired images was performed
by 12 trained readers (Chondrometrics GmbH), with blinding to
acquisition order (baseline vs follow-up) and radiographic status.
All segmentations were quality controlled by one of two experts
(S.M. and F.E.) and were subsequently corrected by the readers, if
necessary.
Segmentation of the total subchondral bone area (tAB) and the
articular cartilage surface area (AC) was performed in the medial
and the lateral tibia (MT/LT), and in the central, weight-bearing
medial and the lateral femoral condyle (cMF/cLF)17. Osteophytes
were excluded from the segmentation. Because the coronal orien-
tation of the FLASH datasets precludes the segmentation of the
posterior parts of the femoral condyle, the weight-bearing parts of
the femoral condyles were deﬁned as the 60% between the anterior
border of the intercondylar notch and the posterior aspects of the
femoral condyles for both the FLASH and the DESS acquisitions16. In
the DESS subsample, segmentationwas performed for every second
of the 0.7 mm slices resulting in a slice thickness of 1.4 mm, as this
was shown to provide a comparable sensitivity to change as the
segmentation of every slice16.
The mean cartilage thickness (ThCtAB) over the tAB was
computed for each of the four femorotibial cartilage plates,
including denuded areas as 0mm thickness18. Lateral compartment
(LFTC) cartilage thickness was computed as the sum of LT and cLF,
and medial compartment (MFTC) cartilage thickness as the sum of
MT and cMF. Subregional changes were computed in central
external, internal, anterior, and posterior subregions of LT and MT,
and in central external, and internal subregions of cLF and cMF18.
Ordered values (OV) of subregional changes represent a location-
independent measure of change in cartilage thickness. OVs are
computed by ordering the change observed in the 16 femorotibial
subregions (each ﬁve in MT and LT and each three in cMF and cLF)
within each knee in ascending order6,19. Ordered value 1 (OV1)
therefore represents the subregionwith the largest decrease (or the
smallest increase) in cartilage thickness and OV 16 the subregionh lateral JSN 1e3 (latJSN), and with medial JSN 1e3 (medJSN) in A) the LFTC and B) the
Fig. 2. MC in ordered values 1e16 (OV 1eOV 16) in knees without JSN (noJSN), with lateral JSN 1e3 (latJSN 1e3), and with medial JSN 1e3 (medJSN 1e3).
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gional cartilage thickness within each knee.
Progressor classiﬁcation
The smallest detectable change (SDC) methodology20 was used
to identify knees with signiﬁcant cartilage thickness loss (pro-
gression) in the LFTC or MFTC. The SDC thresholds were computed
using data from the OAI pilot study13 and were 92 mm (FLASH)/
121 mm (DESS) for the LFTC and 102 mm (FLASH)/111 mm
(DESS) for the MFTC, respectively.
Statistical analysis
The annualized mean change (MC), the standard deviation of
change (SD), and 95% conﬁdence intervals (CI) of change in ThCtAB
were determined between baseline and year 1 follow-up. The
standardized response mean (SRM) was computed by relating the
MC to the SD as a measure of the sensitivity to change. The effect
sizes for the primary and the secondary comparisons were deter-
mined as the mean differences between the changes related to the
pooled SD of the changes.
In the current study, we determined the predictive value of
unicompartimental lateral or medial JSN for both the frequency of
structural progression (i.e., cartilage thickness loss exceeding the
SDC threshold) and for the magnitude of change in cartilage
thickness. Because these two outcomes were considered compli-
mentary to each other and not interpreted separately, we did not
adjust the analyses for two outcomemeasures. The predictive value
of unicompartimental lateral or medial JSN for the frequency of
subsequent cartilage thickness loss in the narrowed compartment
was reported as the probability of subsequent progression under
the condition that JSN was present. The CIs were calculated as
described in21. The predictive value of unicompartimental lateral or
medial JSN for the magnitude of change in ThCtAB was assessed
using non-parametric tests, because the distribution of the change
in ThCtAB violated the assumptions of parametric statistical
models. Non-parametric tests do not allow adjusting for potential
confounding factors like age and BMI, but adjustment for these
factors was not considered necessary given the weak associationbetween change in ThCtAB and the factors age and BMI (R2  0.02)
in the current study.
As primary analysis, we compared the probability of progression
and the magnitude of change between the narrowed compart-
ments of knees with lateral or medial JSN to that observed in the
respective compartment of knees without JSN using Fisher’s exact
tests (probability of progression) and ManneWhitney-U tests
(magnitude of change). The type I error rate was set to P ¼ 0.05/
2 ¼ 0.025 to account for two parallel tests (medial/lateral JSN). The
non-parametric KruskaleWallis test was used to explore differ-
ences in change between knees with different grades of lateral or
medial JSN, andManneWhitney-U tests were used as post-hoc tests
in case the KruskaleWallis test identiﬁed signiﬁcant differences
between groups.
As secondary analyses, we compared the predictive value of
lateral or medial JSN for the probability of progression and
magnitude of change between (1) the narrowed compartment of
knees with lateral JSN (LFTC) and the narrowed compartment of
knees with medial JSN (MFTC) and (2) between the non-narrowed
compartment of JSN knees with the respective compartment of no-
JSN knees. Fisher’s exact (probability) and the ManneWhitney U
test (magnitude) were used for these comparisons. The type I error
rate was set to P ¼ 0.05/2 ¼ 0.025 to account for two parallel
comparisons in the second analysis (medial/lateral JSN). The com-
parison between the narrowed compartment of knees with medial
and lateral JSN was repeated with stratiﬁcation by (medial and
lateral) JSN grades, to explore the impact of JSN grades on the
magnitude of change.
To explore the impact of unicompartimental lateral and medial
JSN on the non-location-speciﬁc magnitude of subregional cartilage
thickness loss, the above tests were also applied to OV 1 and OV 16
without adjustment for parallel comparisons. Analyses were per-
formed using SPSS 20 (IBM Corporation, NY, US).Results
The sample comprised 264 left and 658 right knees from 922
OAI participants. The central radiographic readings classiﬁed 175
(19%) knees as having unicompartimental lateral JSN, 589 (64%)
knees as having unicompartimental medial JSN, and 158 (17%)
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(Table I). Lower JSN grades (1 and 2) were more frequent than
higher grades, both in the lateral andmedial compartment (Table I).
Participants with lateral JSN (63.2  8.9 y) and medial JSN
(62.5  9.0 y) of the analyzed knee were somewhat older than
participants without JSN of the analyzed knee (59.9 8.6, P¼ 0.001,
Table I). The BMI of participants with lateral JSN of the analyzed
knee (29.15.0 kg/m2) was lower than that of participants without
JSN of the analyzed knee (30.0  4.6 kg/m2, P ¼ 0.003), but the BMI
did not differ between participants with medial JSN (30.3  4.8 kg/
m2) and without JSN of the analyzed knee (P ¼ 0.52, Table I). The
interval between the baseline and the 1 year follow-up MRI
acquisition was on average 393  47 days in the FLASH and
380  39 days in the DESS sample.
Narrowed compartment of knees with lateral and medial JSN
The probability of subsequent progression (i.e., cartilage thin-
ning exceeding the SDC threshold) was greater in the narrowed
compartment of knees with lateral JSN or medial JSN than in the
respective compartment of knees without JSN (LFTC lateral JSN vs
no-JSN: 34.9 % 95%CI: [27.8, 41.9] vs 13.3% [8.0, 18.6], P¼ 6.4106;
MFTC medial JSN vs no-JSN: 32.4% [28.6, 36.2] vs 12.7% [7.5, 17.8],
P ¼ 3.0  107).
The mean cartilage thinning was signiﬁcantly greater in the
LFTC of lateral JSN knees (81 mm, 95%CI: [106, 55]) than in the
LFTC of knees without any JSN (8 mm [21, 5], P ¼ 8.2  106,
Table II, Fig. 1). Similarly, MFTC cartilage thinning was signiﬁcantly
greater in knees with medial JSN (63 mm [75, 50]) than in
knees without JSN (2 mm [15, 12], P ¼ 6.0  106, Table II, Fig. 1).
The greater cartilage thinning in JSN knees also resulted in a greater
SRM in the narrowed compartment of JSN knees (Table II). The
effect sizes for these primary analyses are reported in Table IV.
LFTC cartilage thinning tended to be greater in knees with
lateral JSN grades 2/3 than in thosewith grade 1, but the differences
between groups were not signiﬁcant (P ¼ 0.59, Table III). In com-
parison, MFTC cartilage thinning differed signiﬁcantly between
knees with different grades of medial JSN (P ¼ 3.0  106, Table III)
with cartilage thinning being signiﬁcantly greater in knees with
medial JSN 2 and 3 than in knees withmedial JSN 1 (medial JSN 2/3:
P ¼ 2.0  106/0.004, Table III). The cartilage thinning observed in
knees with medial JSN 2 did not differ signiﬁcantly from that
observed in medial JSN 3 knees (P ¼ 0.89, Table III).
Lateral vs medial JSN
The probability of subsequent progression did not differ signif-
icantly between the LFTC in knees with lateral JSN and the MFTC inTable I
Demographics and JSN scores in knees without JSN (noJSN), with lateral JSN (latJSN)
and medial JSN (medJSN)
NoJSN (N ¼ 158) LatJSN (N ¼ 175) MedJSN (N ¼ 589)
Age (SD) 59.9  8.6 63.2  8.9 62.5  9.0
BMI (SD) 30.0  4.6 29.1  5.0 30.3  4.8
Sex (m/f) 40/118 56/119 265/324
MRI (DESS/FLASH) 79/79 105/70 333/256
Lat/medJSN 0 (%) 158 (100.0) 0 (0) 0 (0)
Lat/medJSN 1 (%) 0 (0) 65 (37.1) 270 (45.8)
Lat/medJSN 2 (%) 0 (0) 90 (51.4) 280 (47.5)
Lat/medJSN 3 (%) 0 (0) 20 (11.4) 39 (6.6)
Age: years; BMI: kg/m2; Sex: Number of male (m) and female (f) subjects; MRI:
Number of knees analyzed using the sagittal DESS and the coronal FLASH sequence;
lat/medJSN 0e3: Number and percentage of knees scored as having uni-
compartimental (lateral or medial JSN).knees with medial JSN (P¼ 0.58). Similarly, the MC in the narrowed
compartment (MFTC or LFTC) did not differ signiﬁcantly between
knees with medial and lateral JSN (P ¼ 0.19) and the sensitivity to
change was comparable in the narrowed compartment of knees
with lateral and medial JSN, respectively (0.48 vs 0.41, Table II).
Explorative analyses of MC stratiﬁed by JSN grade did also not differ
signiﬁcantly between knees with lateral and medial JSN (medial vs
lateral JSN1/2/3: P ¼ 0.06/0.83/0.76, Table III). The effect sizes for
this secondary analysis are reported in Table IV.
Non-narrowed compartment of knees with lateral and medial JSN
The probability of subsequent progression did not differ signif-
icantly between the non-narrowed compartment of JSN knees and
the respective compartment of knees without JSN (MFTC progres-
sion in lateral JSN knees: 16.6% [11.1, 22.1], P ¼ 0.35; LFTC pro-
gression in medial JSN knees: 14.9% [12.1, 17.8], P¼ 0.70). The MC in
the non-narrowed compartment (MFTC or LFTC) of knees with
unicompartimental lateral or medial JSN did also not differ signif-
icantly from the MC observed in knees without JSN (MFTC: lateral
vs noJSN: P ¼ 0.23; LFTC: medial JSN vs noJSN: P ¼ 0.60; Table II).
The effect sizes for this secondary analysis are reported in Table IV.
OVs
The change in OV 1 was signiﬁcantly greater in knees with
unicompartimental lateral and medial JSN than in knees without
JSN (lateral/medial JSN: P ¼ 1.1 109/8.7  107, Table II). Change
in OV 1 did not differ signiﬁcantly between knees with lateral JSN 1,
2, or 3 (P ¼ 0.62), but differed signiﬁcantly between knees with
medial JSN 1, 2, or 3 (P ¼ 9.9  109, Table III, Fig. 2). Post-hoc test
showed that OV 1 was signiﬁcantly smaller in medial JSN 1 than in
medial JSN 2 knees (P ¼ 1.5  109) and showed a borderline sig-
niﬁcant difference when comparing OV 1 between knees with
medial JSN 1 and 3 (P ¼ 0.046, Table III). No signiﬁcant difference
was observed for OV1 between knees with medial JSN 2 and 3
(P ¼ 0.27, Table III).
OV 16 was not signiﬁcantly different between knees with lateral
or medial JSN when compared to those without JSN (lateral/medial
JSN: P ¼ 0.25/0.56, Table II), but differed signiﬁcantly between
knees with different grades of lateral JSN (P ¼ 0.02, Table III). Post-
hoc tests showed that OV 16 was signiﬁcantly greater in knees with
lateral JSN 2 than in knees with lateral JSN 3 (P ¼ 0.01, Table III). No
signiﬁcant difference was observed for change in OV 16 between
knees with medial JSN 1, 2, or 3 (P ¼ 0.39). Results for OVs 2e16 are
shown in Online Tables I & II.
When comparing knees with unicompartimental lateral and
medial JSN, OV 1 was signiﬁcantly greater in knees with lateral JSN
1 than in knees with medial JSN 1 (P ¼ 0.004, Table III), However,
OV 1 did not differ signiﬁcantly between knees with higher grades
of medial and lateral JSN (JSN 2: P ¼ 0.72, JSN 3: P ¼ 0.47, Table III).
OV 16 did not differ signiﬁcantly between knees with medial and
lateral JSN 1e3 (P  0.06, Table III).
Stratiﬁcation by MRI sequence (FLASH or DESS) did not change
the principal observations made above (data not shown).
Discussion
The aim of this study was to evaluate the predictive value of
unicompartimental lateral and medial JSN for subsequent struc-
tural change (i.e., cartilage thickness loss) in the narrowed femo-
rotibial compartment of knees with JSN. The results show a
signiﬁcantly greater probability of subsequent progression and a
signiﬁcantly increased magnitude of cartilage thinning in the nar-
rowed (lateral or medial) compartment of JSN knees, when
Table II
Change in cartilage thickness in knees without JSN (noJSN), with lateral JSN (latJSN), and medial JSN (medJSN)
NoJSN LatJSN MedJSN
MC SD CI SRM MC SD CI SRM MC SD CI SRM
LFTC 8 84 21 5 0.09 81 168 106 55 0.48 20 100 28 11 0.20
LT 8 52 16 0 0.15 46 75 57 34 0.61 16 55 20 11 0.29
cLF 0 65 10 10 0.00 35 119 53 17 0.29 4 74 10 2 0.05
MFTC 2 87 15 12 0.02 15 117 33 2 0.13 63 154 75 50 0.41
MT 5 45 2 12 0.11 8 52 15 0 0.15 20 70 26 14 0.29
cMF 6 63 16 4 0.10 8 94 22 6 0.08 43 111 51 34 0.38
OV 1 143 74 155 132 233 169 259 208 207 160 220 194
OV 16 132 79 120 145 140 79 128 152 137 80 130 143
MC, SD of the change, and 95% CIs of the change in cartilage thickness in the LFTC/MFTC, the lateral/medial tibia (LT/MT), the central, weight-bearing part of the lateral/medial
femur (cLF/cMF), the subregion showing the highest negative change within each knee (OV 1), and the subregion showing the highest positive change within each knee (OV
16). The SRM was reported for compartment measures and cartilage plates but not for OVs. All changes in mm.
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medial JSN were found to have a comparable predictive value for
structural progression in the narrowed compartment, but were not
associated with an increased magnitude of cartilage thinning in the
opposite (no JSN) compartment.
It has been previously reported that medial JSN was associated
with greater subsequent structural progression in the MFTC7,22, but
no previous study has comprehensively examined the predictive
value of lateral JSN for progression in the entire LFTC. The focus of
the current study was therefore set on knees with lateral JSN.
However, we also included knees withmedial JSN in the analysis, in
order to compare the predictive value of lateral andmedial JSNwith
subsequent cartilage thinning in the narrowed and non-narrowed
compartment.
Two studies explored the relationship of lateral JSN with tibial
cartilage volume: In a cross-sectional study, Ciccutini et al. reported
a signiﬁcant negative association between lateral JSN and cartilage
volume in the lateral tibia (LT)23. Saunders et al. reported an asso-
ciation between lateral JSN and both medial and lateral cartilage
volume loss in the tibia24, whereas we did not ﬁnd lateral JSN to be
associated with greater medial femorotibial cartilage thickness loss
compared with knees without JSN. A possible explanation is that
the study by Saunders et al. did not control for the ROA status in the
medial compartment of these knees, and that in the lateral JSN
group knees with medial (bicompartimental) JSN were not elimi-
nated. In addition, only a minority of the knees was found to haveTable III
Change in cartilage thickness in knees with lateral and medial JSN stratiﬁed by JSN score
JSN 1 JSN 2
MC SD CI SRM MC SD
Lateral JSN
LFTC 64 132 96 31 0.48 92 193
LT 46 76 64 27 0.60 45 77
cLF 18 84 39 3 0.22 47 140
MFTC: 23 123 53 8 0.18 13 110
MT 13 56 27 0 0.24 1 52
cMF 9 97 33 15 0.09 11 86
OV 1 218 150 255 181 248 190
OV 16 132 65 116 148 149 76
Medial JSN
LFTC 18 97 29 6 0.18 22 104
LT 14 54 21 8 0.27 19 58
cLF 3 69 12 5 0.05 3 75
MFTC: 29 129 44 13 0.22 91 171
MT 7 56 14 1 0.13 31 81
cMF 22 97 33 10 0.22 61 121
OV 1 169 124 184 154 238 157
OV 16 137 72 129 146 137 86
MC, SD of the change , and 95% CIs of the change in cartilage thickness in the LFTC/MFTC
highest negative change within each knee (OV1), and the subregion showing the highest
measures and cartilage plates but not for OVs. All changes in mm.osteophytes (<10%) in this study and these were reported to be
more predictive for cartilage volume loss than JSN (>50% had
medial JSN andw20% had lateral JSN).
Although the radiographic acquisition protocol of the OAI
focused on reproducible delineation of the medial (and not
necessarily the lateral) tibial plateau, we ﬁnd that lateral JSN is of
similar predictive value for subsequent cartilage thickness loss in
the LFTC as medial JSN for progression in the MFTC. The strong
relationship of JSN with structural progression in the same, but not
in the opposite (noJSN) compartment indicates that relying exclu-
sively on Kellgren & Lawrence grades during the enrollment of
participants to clinical trials is suboptimal, if compartment-speciﬁc
(medial or lateral) structural measures are deﬁned as outcomes.
Because of the higher prevalence of medial JSN25, participants
enrolled by having KLG3 or 4 in the target knee are more likely to
show medial than lateral progression. However, the notable
amount of knees with lateral JSN is not likely to contribute to
medial progression. Excluding knees with predominantly lateral
disease26,27, in turn, limits the generalizability of the ﬁndings. To
circumvent this issue, it is possible to select individually, in each
knee, the predominantly affected compartment as a structural
outcome, based on compartment-speciﬁc JSN and osteophyte
scores28. This approach is supported by the similar frequency and
magnitude of change in knees with lateral vs medial JSN in the
current analysis. An alternative, and potentially more efﬁcient,
approach may be the use of non-region speciﬁc measures as1e3
JSN 3
CI SRM MC SD CI SRM
132 51 0.48 85 158 159 11 0.53
61 29 0.58 49 62 78 20 0.79
76 17 0.33 36 114 89 18 0.31
36 10 0.11 5 133 68 57 0.04
12 10 0.03 17 40 36 1 0.44
29 7 0.13 12 120 44 68 0.10
288 208 217 119 272 162
133 164 129 126 70 188
34 10 0.21 16 93 46 14 0.17
25 12 0.32 10 51 26 7 0.18
12 6 0.04 6 94 37 24 0.07
111 71 0.53 92 146 140 45 0.63
40 21 0.38 34 62 54 14 0.55
75 46 0.50 59 102 92 26 0.58
256 219 245 296 341 149
127 147 127 87 98 155
, LT/MT, the central, weight-bearing part of the cLF/cMF, the subregion showing the
positive change within each knee (OV16). The SRM was reported for compartment
Table IV
Absolute effect size for differences in change in cartilage thickness between knees
with lateral JSN, medial JSN, and knees without JSN
Lateral JSN vs noJSN Medial JSN vs noJSN Lateral JSN vs
medial JSN
Narrowed compartment
LFTC/MFTC 0.54 0.43 0.11
LT/MT 0.58 0.38 0.36
cLF/cMF 0.36 0.35 0.07
Non-narrowed compartment
LFTC/MFTC 0.13 0.12 0.04
LT/MT 0.25 0.15 0.15
cLF/cMF 0.02 0.05 0.05
OVs
OV 1 0.68 0.43 0.16
OV 16 0.10 0.05 0.04
LFTC/MFTC; LT/MT; central, weight-bearing part of the cLF/cMF; OVs 1/16: OV 1/OV
16. The effect size was determined as the difference in change related to the pooled
SD of the respective changes for the narrowed compartment (LFTC change in knees
with lateral JSN vs knees without JSN or LFTC change in knees with lateral JSN vs
MFTC change in knees with medial JSN), in the non-narrowed compartment and for
compartment-independent OVs.
W. Wirth et al. / Osteoarthritis and Cartilage 22 (2014) 63e7068outcomes, such as OVs19. These were previously shown to provide a
greater sensitivity to differences in change between KLG2 and KLG3
knees6 and also a greater sensitivity in identifying risk factors of
progression than location-speciﬁc measures29. Given the high
sensitivity to differences in change between knees with lateral JSN
and knees without JSN shown in the current study, and the high
sensitivity to differences in change between knees with and
without medial OA demonstrated previously19, studies including
knees with both medial and lateral OA might beneﬁt greatly from
selecting OVs as outcomes.
Unicompartimental radiographic JSN was found to be a signiﬁ-
cant predictor of subsequent cartilage thickness loss in this study,
and it should be kept in mind that the radiographic joint space
width is not maintained by cartilage only. Meniscus extrusion was
also reported to be associated with change in radiographic JSW30,
and a decreased JSW could therefore be caused by any combination
of cartilage loss andmeniscus extrusion. However, previous studies
have shown that not only preexisting cartilage damages31 but also
meniscus extrusion31,32 is predictive for subsequent cartilage
thickness loss. In a recent cross-sectional study, Bloecker et al.
found a signiﬁcantly lesser coverage of the cartilage by the medial
meniscus in knees with medial JSN than in those without medial
JSN33. Given the important role of themeniscus in load distribution,
a reduced mechanical protection of the cartilage by the meniscus is
likely to accelerate the structural damage, and a recent study has
reported a signiﬁcant association between meniscus lesions and
cartilage thickness loss in adjacent cartilage subregions34.The same
may apply to lateral extrusion of the meniscus in knees with latJSN,
exposure of the LFTC cartilage, and subsequent cartilage loss, but
future work must conﬁrm lateral meniscus position in latJSN knees
to conﬁrm this hypothesis.
A limitation of the current study is the lack of alignment mea-
sures, which are not yet available for the OAI. Several studies have
established a strong association between malalignment and carti-
lage loss35,36. However, from a clinical perspective, JSN grades are
far more simpler to obtain (andmore frequently available in studies
than alignment measures on long limb radiographs). The pro-
gressor deﬁnition used in the current study was based on the SDC
approach20, providing a threshold beyond which change is likely to
be greater than measurement error. However, no threshold has yet
been identiﬁed that relates structural progression directly to a
clinical outcome (e.g., worsening in symptoms) and this should be
addressed in future studies. The results have not been adjusted for
potential confounding factors (e.g., BMI or age). However, BMI andage were quite balanced across JSN categories and were only
weakly associated with change in cartilage thickness when strati-
fying for radiographic disease stage (JSN, R2  0.02). Therefore,
adjustments would not have changed any of the conclusions.
Advanced statistical modeling might allow to further improve the
estimation of the effect of baseline JSN for cartilage loss.
In conclusion, unicompartimental lateral and medial JSN were
found to be strong predictors for structural progression (i.e., carti-
lage thickness loss) in the narrowed femorotibial compartment.
The probability of subsequent lateral cartilage thickness loss in
knees with lateral JSN was comparable to that of medial cartilage
thickness loss in knees with medial JSN and was signiﬁcantly
greater than that in knees without JSN. However, lateral or medial
JSN did not increase the probability or magnitude of subsequent
cartilage thickness loss in the non-narrowed compartment.Contributors
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